Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-08 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-08/5
Series
Methodological standard
Version
1.3
Published
19 Mar 2024
Last reviewed
19 Aug 2024
Next review
19 Aug 2027
Identifier
10.71829/cei.meth.8
Certainty
High
Cycle
2024 Q1
Category
Chromatographic purity

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Hydrolysis recovery of the control peptide95–105 % of expected amino-acid contentHydrolysis completeness
Hydrolysis-induced racemisation blank, Ser and ThrDetermined and reported, typically 1–4 %Blank correction validity
Resolution between D- and L-derivatives≥ 1.5Chiral separation adequacy
Derivatisation reagent enantiomeric purity≥ 99.5 %Absence of reagent-induced artefact

§5.2Acceptance criteria

  • Corrected D content at any position designed to be L is reported as determined; the Institute sets no universal limit but records that a value above 2 % after blank correction indicates a coupling problem.
  • A determination without a reported hydrolysis blank is not reportable, because uncorrected serine and threonine racemisation of several per cent will otherwise be attributed to the synthesis.
  • Tryptophan configuration cannot be determined by acid hydrolysis and requires an alternative hydrolysis or an intact-peptide method.

§5.3Limitations

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.